Skip to main content
. 2009 Nov;68(5):690–699. doi: 10.1111/j.1365-2125.2009.03516.x

Figure 3.

Figure 3

The simulated concentrations time-course after a single dose of 600 mg efavirenz in four typical subjects, based on the final efavirenz pharmacogenetic/pharmacokinetic model. Wild-type: CYP2B6516G/G, CYP2B6*11G/G and ABCB1 rs3842A/A (19.0%). Homozygous mutant: CYP2B6516T/T, CYP2B6*11T/T and ABCB1 rs3842 G/G (2.7%)